CHU Toulouse - Hôpital Rangueil

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Re-Treatment With ALXN2220 in Patients With ATTR-CM	Nutritional and Metabolic Diseases, amyloidosis, metabolic disease, proteostasis deficiencies	Active, not recruiting	Phase 2	2026-10-07		NCT07213583

Clinical trials